Migraine is one of the most prevalent and disabling conditions worldwide. Treatment of migraine can involve both acute and preventive interventions. Patients with frequent headache mayrequire both approaches. Acute treatment is aimed at aborting the headache attack, whereas preventive treatment is geared toward reducing the frequency and severity of attacks.
Titolo: | Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center | |
Autore/i: | Matteo E.; Favoni V.; Pascazio A.; Pensato U.; Benini M.; Asioli G. M.; Merli E.; Calabro C.; Cortelli P.; Pierangeli G.; Cevoli S. | |
Autore/i Unibo: | ||
Anno: | 2020 | |
Rivista: | ||
Digital Object Identifier (DOI): | http://dx.doi.org/10.1007/s10072-020-04667-0 | |
Abstract: | Migraine is one of the most prevalent and disabling conditions worldwide. Treatment of migraine can involve both acute and preventive interventions. Patients with frequent headache mayrequire both approaches. Acute treatment is aimed at aborting the headache attack, whereas preventive treatment is geared toward reducing the frequency and severity of attacks. | |
Data stato definitivo: | 2021-02-03T07:57:19Z | |
Appare nelle tipologie: | 1.01 Articolo in rivista |
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.